Results 161 to 170 of about 195,674 (187)

Coronary ischemia and percutaneous intervention [PDF]

open access: possibleCardiovascular Pathology, 2010
The interventional treatment of ischemia is a complex issue grounded on an understanding of basic pathophysiology, but translated and implemented in practice by extensive clinical trial data representing patients with a spectrum of ischemia-causing clinical syndromes and anatomical variations of coronary artery disease (CAD).
Michael S. Kim   +2 more
openaire   +2 more sources

Is facilitated percutaneous coronary intervention superior to primary percutaneous coronary intervention? [PDF]

open access: possibleNature Clinical Practice Cardiovascular Medicine, 2006
Is facilitated percutaneous coronary intervention superior to primary percutaneous coronary intervention?
openaire   +2 more sources

Cangrelor in percutaneous coronary intervention

Expert Review of Clinical Pharmacology, 2009
Cangrelor is a novel, intravenous P2Y12 receptor antagonist in development for use in percutaneous coronary intervention. Currently in Phase III testing, the reversible platelet inhibitor provides several inherent advantages over other P2Y12 receptor antagonists in this setting for the prevention of adverse cardiac events.
Julie H. Oestreich, Steven R. Steinhubl
openaire   +3 more sources

Percutaneous Coronary Intervention

2016
There are over one million percutaneous coronary interventions (PCI) performed each year in the United States. PCI refers to catheter- based procedures that allow for improved perfusion through epicardial coronary arteries to the myocardium. PCI originally referred to percutaneous transluminal coronary angioplasty, a solely balloon-based procedure, but
Manny C. Katsetos   +2 more
openaire   +2 more sources

Percutaneous coronary intervention in the elderly

Nature Reviews Cardiology, 2010
In contemporary practice, more than one in five patients treated with percutaneous coronary intervention (PCI) are aged ≥75 years and the proportion of elderly individuals in the population is growing. The elderly have more cardiovascular risk factors and a greater burden of ischemic disease than younger patients needing PCI and, therefore, derive ...
Antonio Gutierrez   +2 more
openaire   +3 more sources

Percutaneous coronary intervention in the elderly

International Journal of Cardiology, 2015
Our population dynamics are changing. The number of octogenarians and older people in the general population is increasing and therefore the number of older patients presenting with acute coronary syndrome or stable angina is increasing. This group has a larger burden of coronary disease and also a greater number of concomitant comorbidities when ...
Sunil K. Nadar, Kully Sandhu
openaire   +3 more sources

Percutaneous Intervention of Coronary Aneurysm

Cardiovascular Revascularization Medicine, 2020
The coronary artery aneurysm (CAA) is not a frequent condition in the catheterization laboratory. The management is uncertain. Most of the cases, the treatment is surgical with good results. In smaller aneurysm, the use of covered stents is an alternative. This is an anterograde approach CTO (chronic total occlusion) case of a middle segment RCA (right
Rodrigo Monsalve   +6 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy